A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab

Clinical trial NCT07422337 · RECRUITING

Trial details

NCT number: NCT07422337
Sponsor: Arkansas Children's Hospital Research Institute
Status: RECRUITING
Study type: OBSERVATIONAL

B-Cell ALL B-Cell Acute Lymphoblastic Leukaemia B-Cell Lymphoblastic Leukemia B-Cell Lymphoblastic Leukemia/Lymphoma B-cell Acute Lymphoblastic Leukemia (B-ALL)B-cell Acute Lymphoblastic Leukemia B-cell Childhood Acute Lymphoblastic Leukemia B-cell Leukemia

Start date: 2026-01-13
Primary completion: 2028-01-01
Enrollment: 300

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.